These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20142122)

  • 1. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
    Mabru M; Dacher JN; Bauer F
    Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis.
    Bucciarelli-Ducci C; Locca D; Barbeau G; Prasad SK
    Eur Heart J; 2007 May; 28(10):1186. PubMed ID: 17121755
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of phase-sensitive inversion recovery sequence to perform and analyse late gadolinium enhancement in cardiac amyloidosis.
    Gerbaud E; Lederlin M; Laurent F
    Arch Cardiovasc Dis; 2009 Dec; 102(12):859-60. PubMed ID: 19963197
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiologic or pathologic hypertrophy: how can we know?
    Lai EJ; Rakowski H
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):919-22. PubMed ID: 24972675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging hypertrophic heart diseases with cardiovascular MR.
    Proctor RD; Shambrook JS; McParland P; Peebles CR; Brown IW; Harden SP
    Clin Radiol; 2011 Feb; 66(2):176-86. PubMed ID: 21216334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods].
    Masuda Y
    Nihon Rinsho; 2000 Jan; 58(1):218-22. PubMed ID: 10885317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
    Maron MS; Lesser JR; Maron BJ
    Am J Cardiol; 2010 Jun; 105(12):1842-3. PubMed ID: 20538141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance imaging in Danon disease.
    Nucifora G; Miani D; Piccoli G; Proclemer A
    Cardiology; 2012; 121(1):27-30. PubMed ID: 22378182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.
    Maron BJ; Lindberg J; Haas TS; Kitner C; Lesser JR
    Am J Cardiol; 2010 Jun; 105(11):1643-4. PubMed ID: 20494677
    [No Abstract]   [Full Text] [Related]  

  • 11. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
    Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
    Kohno I; Komori S; Yamamoto K; Sano S; Ishihara T; Umetani K; Sawanobori T; Ijiri H; Tamura K
    Intern Med; 2000 Aug; 39(8):637-40. PubMed ID: 10939537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palpitations in a 64-year-old man.
    Bauml MA; Chung J; Groth JV; Farzaneh-Far A
    Heart; 2014 Jan; 100(2):167-8. PubMed ID: 24281755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed gadolinium enhancement and elevated plasma brain natriuretic peptide are useful in differentiating hypertrophic cardiomyopathy from athlete's heart.
    Cheng TO
    J Cardiol; 2009 Apr; 53(2):314-5; author reply 315. PubMed ID: 19304140
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles.
    Yilmaz A; Sechtem U
    Heart; 2014 Apr; 100(8):662-71. PubMed ID: 23633547
    [No Abstract]   [Full Text] [Related]  

  • 16. A strong negative correlation was found between heart rate variability and left ventricular mass in patients with cardiac hypertrophy.
    Faludi R; Toth L
    Am Heart J; 2006 Jul; 152(1):e13; author reply e15. PubMed ID: 16824819
    [No Abstract]   [Full Text] [Related]  

  • 17. An interesting case of cardiac amyloidosis initially diagnosed as hypertrophic cardiomyopathy.
    Boufidou A; Mantziari L; Paraskevaidis S; Karvounis H; Nenopoulou E; Manthou ME; Styliadis IH; Parcharidis G
    Hellenic J Cardiol; 2010; 51(6):552-7. PubMed ID: 21169191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
    Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated left ventricular non-compaction, not hypertrophic cardiomyopathy.
    McCulloch C; Jadhav S; Glen S; Bridges A
    QJM; 2004 Dec; 97(12):827-8. PubMed ID: 15569815
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular hypertrophy: diagnostics pitfalls.
    Bonvini RF; Camenzind E
    Swiss Med Wkly; 2004 May; 134(19-20):289-92. PubMed ID: 15243850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.